Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Fowler

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|September 12, 2015
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphomaKoichi Takahashi, Mariela Sivina, Julia Hoellenriegel, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation TherapyAlison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphomaChelsea C Pinnix, Grace L Smith, Sarah Milgrom, et al.
Cancer|May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphomaJorge E Romaguera, Michael Wang, Lei Feng, et al.
Leukemia & Lymphoma|May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapyKarine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2018
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS LymphomaSarah A Milgrom, Chelsea C Pinnix, T Linda Chi, et al.
Haematologica|November 27, 2025
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphomaErel Joffe, Manik Uppal, Serena Zheng, et al.
Blood Advances|January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvementSerkan Akin, Chitra Hosing, Issa Khouri, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomographyChelsea C Pinnix, Bouthaina Dabaja, Mohamed Amin Ahmed, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|September 12, 2015
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphomaKoichi Takahashi, Mariela Sivina, Julia Hoellenriegel, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 27, 2018
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation TherapyAlison K Yoder, Jillian R Gunther, Sarah A Milgrom, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphomaChelsea C Pinnix, Grace L Smith, Sarah Milgrom, et al.
Cancer|May 4, 2018
Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphomaJorge E Romaguera, Michael Wang, Lei Feng, et al.
Leukemia & Lymphoma|May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapyKarine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2018
Radiation Therapy as an Effective Salvage Strategy for Secondary CNS LymphomaSarah A Milgrom, Chelsea C Pinnix, T Linda Chi, et al.
Haematologica|November 27, 2025
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphomaErel Joffe, Manik Uppal, Serena Zheng, et al.
Blood Advances|January 10, 2022
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvementSerkan Akin, Chitra Hosing, Issa Khouri, et al.
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomographyChelsea C Pinnix, Bouthaina Dabaja, Mohamed Amin Ahmed, et al.
Pageof 9